OVERVIEW
The global market for measuring creatinine is projected to hit USD 788.23 million by 2025, rising over the forecast period at a CAGR of 7.54 per cent. Increasing the incidence of renal disorders, growing the incidence of other chronic disorders affecting renal function, rising recognition and acceptance of preventive healthcare strategies, introducing favorable policy policies to encourage renal health, and rapid growth in the geriatric population and increasing numbers of drug development policies are driving this market growth.
TABLE OF CONTENT
1 Global Creatinine Measurement Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Creatinine Measurement Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Creatinine Measurement Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Creatinine Measurement Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Creatinine Measurement Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Creatinine Measurement Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Creatinine Measurement Market – By Type (Market Size – & million/billion)
8.1 Jaffe’s kinetic method
8.2 Enzymatic method
9 Global Creatinine Measurement Market – By Type of Sample
9.1 Blood/serum
9.2 Urine
10 Global Creatinine Measurement Market – By Product
10.1 Reagents
10.2 Kits
11 Global Creatinine Measurement Market – By End-User
11.1 Hospitals
11.2 Diagnostic Laboratories
12 Global Creatinine Measurement Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Creatinine Measurement Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Creatinine Measurement Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Siemens Healthineers (A Division of Siemens AG)
14.3 F. Hoffmann-La Roche Ltd.
14.4 Abbott Laboratories
14.5 Danaher Corporation (Beckman Coulter)
14.6 Pointe Scientific, Inc (A Part of Medtest Holdings)
14.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd
14.8 Ortho Clinical Diagnostics
14.9 Thermo Fisher Scientific Inc.
14.10 Randox Laboratories
14.11 Wako Pure Chemical Industries, Ltd
14.12 Company 11 & more
15 Global Creatinine Measurement Market – Appendix
15.1 Sources
15.2 Abbreviations
